Vitamin K in infancy†
References (83)
- et al.
The role of vitamin K in the etiology, prevention, and treatment of hemorrhage in the newborn infant
J Pediatr
(1939) - et al.
The relation of vitamin K deficiency to hemorrhagic disease of the newborn
Adv Pediatr
(1952) - et al.
Coagulation changes in the neonatal period and in early infancy
Pediatr Clin North Am
(1962) Hemorrhage in the newborn and vitamin K prophylaxis
J Pediatr
(1962)Protein-C: Biochemistry, physiology, and clinical implications
Blood
(1983)- et al.
Factor II (prothrombin) levels in cord blood: Correlation of coagulant activity with immunoreactive protein
J Pediatr
(1980) - et al.
Plasma vitamin K1 in mothers and their newborn babies
Lancet
(1982) The vitamin K-dependent proteins
Adv Pediatr
(1981)- et al.
The content of phylloquinone (vitamin K1) in human milk, cow's milk and infant formula foods determined by high-performance liquid chromatography
J Nutr
(1982) - et al.
Absorption of vitamin K from the colon in the newborn infant
J Pediatr
(1966)
Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy
Lancet
Haemorrhagic disease of the newborn returns
Lancet
Transplacental vitamin K prevents haemorrhagic disease of the infant of epileptic mother [letter]
Lancet
Phenytoin, hemorrhage, skeletal defects and vitamin K in the newborn
Med Hypotheses
Vitamin K deficiency causing infantile intracranial haemorrhage after the neonatal period
Lancet
Epidemic of haemorrhagic disease in Vietnamese infants caused by warfarin-contaminated talcs
Lancet
Factor II (prothrombin) coagulant activity and immunoreactive protein: Detection of vitamin K deficiency and liver disease in patients with cystic fibrosis
J Pediatr
Is warfarin sodium contra-indicated in the lactating mother?
J Pediatr
Heparin-like inhibitor, not vitamin-K deficiency, in the newborn
Lancet
Vitamin K deficiency in the newborn
Lancet
Vitamin K and the newborn
Lancet
Vitamin K1 for all newborn babies
Lancet
Vitamin K-dependent clotting factors in normal breast-fed infants
J Pediatr
The haemorrhagic disease of the newborn
Arch Pediatr
Cholesterinstoffwechsel in hühnereiern und hühnchen
Biochem Zeitschr
Plasma prothrombin level in normal infancy and in hemorrhagic disease of the newborn
Am J Med Sci
Prophylactic and curative effect of vitamin K in hemorrhagic disease of the newborn
Acta Obstet Gynecol Scand
Vitamin K compounds and the water-soluble analogues: Use in therapy and prophylaxis in pediatrics
Pediatrics
Recent findings in understanding the biological function of vitamin K
Med Biol
Hepatic vitamin K-dependent carboxylation of blood-clotting proteins
Hepatology
Carboxylated calcium-binding proteins and vitamin K
N Engl J Med
Vitamin K-dependent modifications of glutamic acid residues in prothrombin
Proc Natl Acad Sci USA
Perinatal coagulation
A simple and rapid test for PIVKA-II in plasma
Thromb Res
Immunologic studies of prothrombin in newborns
Pediatr Res
Evidence against vitamin K deficiency in normal neonates
Thromb Haemost
Acquired vitamin K-dependent carboxylation deficiency in liver disease
N Engl J Med
The substances involved in the coagulation of blood of the newborn
Am J Dis Child
Intestinal absorption of vitamins A, E, D, and K
J Lab Clin Med
Biosynthesis of vitamin K (menaquinone) in bacteria
Microbiol Rev
Role of feeding and vitamin K in hypoprothrombinemia of the newborn
Am J Dis Child
Cited by (211)
Vitamin K in human health and metabolism: A nutri-genomics review
2022, Trends in Food Science and TechnologyCitation Excerpt :Poor VK carriage through placenta, low content of VK1 in breast milk, and liver immaturity leads to inefficient use of VK and recycling represent part of the conditions further leads to a situation known as VK deficiency bleeding (VKDB) (American Academy of Pediatrics Committee on Fetus and Newborn, 2003; Pichler & Pichler, 2008). There are three types of VKDB as follows: early-onset (occurs within the first 24 h after birth), classic (occurs within 2–7 days), and late-onset (occurs between 2 and 12 weeks and up to 6 months) (Lane & Hathaway, 1985). Early-onset VKDB or Early haemorrhagic disease of the newborn (Early HDN) is commonly associated with maternal malabsorption disorders and medications that inhibit the activity of VK, such as antiepileptics (carbamazepine, phenytoin, and barbiturates), anti-tuberculosis medications (isoniazid and rifampicin), certain antibiotics (cephalosporins), and VK antagonists (Warfarin/Coumadin).
Intracranial Hemorrhage
2018, Volpe's Neurology of the NewbornVitamin K insufficiency and the prophylaxis strategy in term healthy infants: A multicentre study
2024, European Journal of Clinical InvestigationRectal Bleeding in Infants: Diagnostic Work-up and Management
2024, Current Pediatric ReviewsIntracranial Hemorrhages in Neonates: Incidence, Risk Factors, and Treatment
2023, Seminars in Thrombosis and Hemostasis50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment
2023, Seminars in Thrombosis and Hemostasis
- †
Supported in part by Grant 2794-7 from the Thrasher Research Fund.